UK markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
29.98-0.22 (-0.73%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close30.20
Open30.37
Bid29.96 x 900
Ask29.97 x 1100
Day's range29.52 - 30.50
52-week range18.37 - 34.81
Volume2,823,088
Avg. volume4,223,811
Market cap14.175B
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)-1.27
Earnings date07 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est33.82
  • Elanco Confirms Date and Conference Call for First Quarter 2021 Financial Results Announcement
    Business Wire

    Elanco Confirms Date and Conference Call for First Quarter 2021 Financial Results Announcement

    Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2021 financial results on Friday, May 7, 2021. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance.

  • 3 Top Pet Healthcare Stocks to Buy Now
    Motley Fool

    3 Top Pet Healthcare Stocks to Buy Now

    Today, let's look at three companies in this sector, Elanco (NYSE: ELAN), Trupanion (NASDAQ: TRUP), and IDEXX Laboratories (NASDAQ: IDXX), and how they can add both bark and bite to your portfolio. Elanco is a pharmaceutical company that develops medications and vaccines for pets and livestock.

  • This New Drug Can Make Farming More Environmentally Sustainable
    Motley Fool

    This New Drug Can Make Farming More Environmentally Sustainable

    Livestock farming has had its problems with greenhouse gas emissions, and the push for cleaner production has brought the need for innovations. Enter Elanco Animal Health (NYSE: ELAN), an animal pharmaceutical company that may have a new product that can help make farming more environmentally sustainable. Elanco has received approval for a drug called Experior that can reduce emissions for feedlot cattle.